Opaleye Management Inc. has demonstrated a clear buying bias in its recent trading activity, with 21 purchases compared to just four sales across two primary holdings—ACOG and SLGL—according to SEC Form 4 filings. The firm has aggressively accumulated shares of ACOG, with purchases totaling over $1.2 million in March 2026 alone, including a $243,632 buy on March 5 and a $266,872 transaction on March 3. Smaller but consistent acquisitions, such as a $28,751 purchase on March 3 and a $116,000 buy on March 2, further reinforce this pattern. The firm also made a significant investment in SLGL, with two purchases on March 24 worth a combined $2.86 million.
In contrast, Opaleye’s selling activity has been concentrated in HROW, with four sales in early March totaling approximately $7.5 million, including a $5.32 million transaction on March 4 and a $2.31 million sale on March 3. Despite these disposals, the firm’s overall trading skews toward accumulation, with net buying activity outweighing sales. The consistency and size of the ACOG purchases, alongside the SLGL investment, suggest a deliberate shift in positioning, though the rationale remains undisclosed in regulatory filings. The data reflects a focused strategy, with Opaleye directing capital toward select holdings while reducing exposure to others.
AI-assisted summary